Article

Platelet miRNA bio-signature discriminates between dementia with Lewy bodies and Alzheimer disease: A cross-sectional study.

2020-05-20

Abstract excerpt

<title>Abstract</title> <p>Background Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia after Alzheimer’s disease (AD) and presents pathological and clinical overlap with both AD and Parkinson’s disease (PD). Consequently, only one in three DLB cases is diagnosed correctly. Platelets have been previously related to neurodegeneration. They contain microRNAs (miRNAs), and th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7a30786a-47eb-5d3a-87d4-dff2c3134d1f
DOI: 10.21203/rs.3.rs-29100/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Platelet miRNA bio-signature discriminates between dementia with Lewy bodies and Alzheimer disease: A cross-sectional study.DOI 10.21203/rs.3.rs-29100/v1Read

Platelet miRNA bio-signature discriminates between dementia with Lewy bodies and Alzheimer diseaseSemantic proximity Read

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophySemantic proximity Read

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read

A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression data.Semantic proximity Read

Circulating micro-RNAs Differentially Expressed in Korean Alzheimer’s Patients with Brain Aβ Accumulation Activate AmyloidogenesisSemantic proximity Read

Platelet miRNAs as early biomarkers for progression of idiopathic REM sleep behavior disorder to a synucleinopathySemantic proximity Read

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brainsSemantic proximity Read

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read

Literature-Identified Serum miRNA Signatures for Cognitive Decline: Integrated Analysis and Machine-Learning Diagnostics in Alzheimer’s DiseaseSemantic proximity Read

MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysisSemantic proximity Read

miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s diseaseSemantic proximity Read

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s diseaseSemantic proximity Read